http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106580995-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 |
| filingDate | 2016-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106580995-B |
| titleOfInvention | Purposes of the phenazine-1-carboxylic acid as medusocongestin fibrinogenase inhibitor |
| abstract | Purposes the invention discloses phenazine-1-carboxylic acid as medusocongestin fibrinogenase inhibitor, the structural formula of the phenazine-1-carboxylic acid is as shown in formula I.Phenazine-1-carboxylic acid is by inhibiting the B β chains of medusocongestin fibrinogenase hydrolysis of fibrin original to play the role of inhibiting medusocongestin fibrinogenase vigor.The present invention provides theoretical reference to screen the micromolecular compound of water resistant parent toxin, and the development that drug is also stung for jellyfish lays the foundation. |
| priorityDate | 2016-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.